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Abstract 
An Activated Sludge Modelling framework for Xenobiotics (ASM-X) was recently developed to 
mechanistically predict the fate of pharmaceuticals in a full-scale treatment plant. In this study, we 
generalized ASM-X to international literature data. Through the generalization, we assessed the 
influence on the biological removal efficiency of specific factors, namely influent loading 
dynamics, SRT and retransformation processes (from e.g., human metabolites back to parent 
chemicals). With regard to the latter, we show that the estimation of removal efficiency based only 
on parent chemical (a predominant practice in literature) can lead to an underestimation of the 
environmental risk.  
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INTRODUCTION 
Dynamic fate models can represent a cost-saving option to investigate the elimination of xenobiotic 
trace chemicals in biological wastewater treatment plants (WWTPs). An Activated Sludge 
Modelling framework for Xenobiotics (ASM-X) was developed and validated in the fate prediction 
of pharmaceuticals in a full-scale WWTP (Plósz et al., 2010, 2012). These studies highlighted the 
potential impact of human conjugated metabolites or other commercial chemicals to retransform 
back to parent forms, leading to a distinction between the concentration of parent (CLI) and 
retransformable fractions (CCJ) of pharmaceuticals. In this study, we validated ASM-X by 
comparing predicted removal efficiencies of three pharmaceuticals (sulfamethoxazole, 
ciprofloxacin and tetracycline) in Bekkelaget WWTP (Oslo, Norway), with published international 
data whereby sound sampling techniques were used. The validation with literature data, also 
referred to as generalization (Plósz et al., 2012), aimed at: (i) assessing the underestimation of 
removal by considering only the parent fraction; (ii) estimating the significance of this 
underestimation in terms of risk predictions; and (iii) evaluating factors known to affect 
pharmaceuticals removal. With regard to (iii), we focused on dynamics of influent load of the 
substances, WWTP operation (e.g., solid retention time—SRT) and retransformation occurring in 
upstream sewer systems.    
 
MATERIALS AND METHODS 
The full-scale implementation of ASM-X in WEST 2012®, calibrated with the results of batch 
experiments as presented by Plósz et al. (2010), was used to estimate the elimination of 
sulfamethoxazole, ciprofloxacin and tetracycline in Bekkelaget WWTP. We distinguished between 
removal efficiency [-], in the biological treatment, referred to parent fraction (Eq.1) and to both 
parent and retransformable fraction (Eq. 2) 
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where Cin and Ceff [ng L
-1
] were concentrations in secondary influent and effluent, respectively. 
Estimated removal efficiencies were plotted as a function of the normalized influent load of the 
chemicals [mg h
-1
 1000PE
-1
], calculated from the design population equivalent of the WWTP. A 
literature review was performed for the generalization of ASM-X predictions, with the collection of 
international data on the full-scale removal of pharmaceuticals. Only data derived from flow-
proportional sampling campaigns were included. Additionally, literature studies on the separate 
treatment of hospital wastewater were selected to characterize a “zero-catchment” scenario, 
describing the removal of pharmaceuticals in WWTPs with negligible upstream sewer transport.  
A preliminary environmental risk assessment of the pharmaceuticals was performed. Predicted 
environmental concentrations (PECs) were estimated from the effluent concentrations from 
Bekkelaget WWTP (assuming 10-fold dilution). We distinguished between PECs accounting for 
only effluent CLI, and for both effluent CLI and CCJ. PECs were then compared to predicted non-
effect concentrations (PNECs) reported in literature to assess risk dynamics.  
 
RESULTS AND DISCUSSION (the case of sulfamethoxazole) 
Scenario simulations, considering increased influent loads compared to measurements in 
Bekkelaget WWTP, were used to generalise ASM-X predictions of sulfamethoxazole removal with 
literature data. In Fig. 1a, we compared model predictions (5-fold increased influent loading) with 
removal efficiencies of sulfamethoxazole in municipal WWTPs. Predicted ηLI and ηTOT were 
consistent with data reported by Göbel et al. (2005, 2007), including a comparable underestimation 
of the efficiency when the retransformable metabolite (N4-acetyl sulfamethoxazole) was not 
considered. A similar underestimation error was shown by Yang et al. (2011). Values of ηLI 
reported by Radjenovic et al. (2009) were significantly higher than our estimations and any other 
literature data at comparable influent loads, suggesting a possible enhancement of 
biotransformation (due to e.g., operation at high SRT). With regard to the zero-catchment scenario 
(Fig. 1b), predicted ηLI and ηTOT at a 25-fold increased load are in close agreement with values 
reported by Kovalova et al. (2012). 
 
Figure 1. Generalization of ASM-X predicted removal of sulfamethoxazole (SMX) with literature data for municipal 
WWTPs (a) and for the hospital wastewater treatment—zero-catchment scenario (b). ASM-X predictions of removal 
efficiency accounted for only parent SMX (grey diamonds) and for parent and retransformable fractions of SMX (black 
circles). 5-fold and a 25-fold increased influent load, as compared to Plósz et al. (2010), were used for the validation in 
(a) and (b), respectively. Error bars refer to standard deviations in influent loads and removal efficiencies.  
 
In Fig. 2, values of the PECs in the recipient water body of the Bekkelaget WWTP were shown. 
Results obtained in this preliminary assessment suggest that tetracycline (Fig. 2a) and—
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significantly—ciprofloxacin (Fig. 2b) can represent a considerable chemical risk. The predicted 
effluent CCJ of tetracycline can pose a substantial additional risk (up to 130% increase as compared 
to parent-based PEC), whereas the parent-based tetracycline results suggested a marginal violation 
of the no-effect limit. Estimated as 131–397 times higher than the respective PNEC value, PECs of 
ciprofloxacin exhibited a marked temporal variability (3-fold increase at the peaks).  
 
Figure 2. PEC values of tetracycline (a) and ciprofloxacin (b) calculated from ASM-X predictions. For PNEC values 
used, please refer to Grung et al. (2008). Quasi MECs (measured environmental concentrations) identify effluent 
measured environmental concentrations divided by a dilution factor. 
 
Overall, these results suggest the importance of using dynamic models for and the necessity of 
considering retransformable chemical fractions in assessing pharmaceuticals removal in biological 
WWTPs. Additionally, we show that environmental risk assessments should account for (i) 
concentrations of retransformable chemicals released in WWTP effluents, potentially representing 
an additional source of hazard; and (ii) temporal variations in effluent concentrations. 
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